Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer

NCT00677144 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasm

Interventions

DRUG: OS (oxalipaltin+S-1)
DRUG: XELOX (oxalipaltin+capecitabine)

Sponsor

Hallym University Medical Center

Collaborators

[object Object]